Abstract
We screened for selective inhibitors of mammalian DNA polymerase (Pol) species from natural products. We then identified compounds that are potential anticancer agents based on Pol inhibition. In this review, the focus is on symbiotic microorganisms that grow on wild marine plants and which could be used as a new screening source for anticancer compounds. The fungal strains were isolated from wild marine plants such as seaweeds and sea mosses collected in Japan. Nine novel compounds were isolated from the cultured broth extracts of isolated fungal strains. These compounds showed bioactivities such as selective inhibition of mammalian Pol activity among 10 mammalian Pol species and suppression of proliferation of human cancer cells while having no effect on the growth of normal human cells. The probability of discovering novel compounds from such sources is high. Therefore, microorganisms derived from wild marine plants appear to be a good screening source for bioactive compounds compared with other naturally occurring materials.
Keywords: Marine microorganism, Seaweeds, Sea mosses, DNA polymerase (E.C.2.7.7.7), Enzyme inhibitor, Cytotoxicity, Anticancer drug
Current Organic Chemistry
Title:Novel Compounds from Marine Microorganisms that Inhibit Mammalian DNA Polymerase
Volume: 16 Issue: 24
Author(s): Yoshiyuki Mizushina, Isoko Kuriyama and Hiromi Yoshida
Affiliation:
Keywords: Marine microorganism, Seaweeds, Sea mosses, DNA polymerase (E.C.2.7.7.7), Enzyme inhibitor, Cytotoxicity, Anticancer drug
Abstract: We screened for selective inhibitors of mammalian DNA polymerase (Pol) species from natural products. We then identified compounds that are potential anticancer agents based on Pol inhibition. In this review, the focus is on symbiotic microorganisms that grow on wild marine plants and which could be used as a new screening source for anticancer compounds. The fungal strains were isolated from wild marine plants such as seaweeds and sea mosses collected in Japan. Nine novel compounds were isolated from the cultured broth extracts of isolated fungal strains. These compounds showed bioactivities such as selective inhibition of mammalian Pol activity among 10 mammalian Pol species and suppression of proliferation of human cancer cells while having no effect on the growth of normal human cells. The probability of discovering novel compounds from such sources is high. Therefore, microorganisms derived from wild marine plants appear to be a good screening source for bioactive compounds compared with other naturally occurring materials.
Export Options
About this article
Cite this article as:
Mizushina Yoshiyuki, Kuriyama Isoko and Yoshida Hiromi, Novel Compounds from Marine Microorganisms that Inhibit Mammalian DNA Polymerase, Current Organic Chemistry 2012; 16 (24) . https://dx.doi.org/10.2174/138527212804546778
DOI https://dx.doi.org/10.2174/138527212804546778 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Potential Use of Protease Inhibitors as Vaginal and Colorectal Microbicides
Current HIV Research Peptidic Tumor Targeting Agents: The Road from Phage Display Peptide Selections to Clinical Applications
Current Pharmaceutical Design Microarray Analysis of Human Epithelial Cell Responses to Bacterial Interaction
Infectious Disorders - Drug Targets Alternative Splicing, DNA Damage and Modulating Drugs in Radiation Therapy for Cancer
Anti-Cancer Agents in Medicinal Chemistry Two Diseases with One Hit: Inhibiting a Potential Diabetes Target to Reduce Cancer Risk and to Improve Anti-Cancer Therapy
Current Cancer Therapy Reviews Drug Metabolism and Individualized Medicine
Current Drug Metabolism Management of Antineutrophil Cytoplasmic Antibody Associated Vasculitis
Current Immunology Reviews (Discontinued) Truncated Lactoferricin Peptide Controls Cervical Cancer Cell Proliferation <i>via</i> lncRNA-NKILA/NF-κB Feedback Loop
Protein & Peptide Letters Advances in Neuroimaging for HIV-1 Associated Neurological Dysfunction: Clues to the Diagnosis, Pathogenesis and Therapeutic Monitoring
Current HIV Research Predictive Efficacy Biomarkers of Programmed Cell Death 1/Programmed Cell Death 1 Ligand Blockade Therapy
Recent Patents on Anti-Cancer Drug Discovery Tumor-Targeted Inhibition by a Novel Strategy - Mimoretrovirus Expressing siRNA Targeting the Pokemon Gene
Current Cancer Drug Targets Assessment and Management of the Adnexal Mass in the Pediatric Population
Current Women`s Health Reviews Botulinum Toxin: Pharmacology and Clinical Developments: A Literature Review
Medicinal Chemistry Combining Angiogenesis Inhibitors with Radiation: Advances and Challenges in Cancer Treatment
Current Pharmaceutical Design Principles of Minimally Invasive Parathyroidectomy
Current Medical Imaging Characterization of Cepharanthin Nanosuspensions and Evaluation of Their In Vitro Activity for the HepG2 Hepatocellular Carcinoma Cell Line
Anti-Cancer Agents in Medicinal Chemistry Design and Synthesis of 3,4-diarylpyrrole Analogues as Potent Topoisomerase Inhibitors
Medicinal Chemistry Biosurfactants as a Novel Additive in Pharmaceutical Formulations: Current Trends and Future Implications
Current Drug Metabolism Berberine Exhibits Antitumor Effects in Human Ovarian Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Structure and Expression of Different Serum Amyloid A (SAA) Variants and their Concentration-Dependent Functions During Host Insults
Current Medicinal Chemistry